NCLT Recalls Alchemist Insolvency Amidst ED Fraud Probe

The Regulatory Sword: Insolvency Process Recalled

The National Company Law Tribunal (NCLT) in New Delhi has formally recalled the Corporate Insolvency Resolution Process (CIRP) initiated against Alchemist Limited. This significant judicial action, dated February 3, 2026, follows decisive intervention by the Enforcement Directorate (ED). The Tribunal's order unequivocally states that the insolvency proceedings were vitiated by fraud, collusion, and malicious intent, thereby preventing the misuse of the Insolvency and Bankruptcy Code (IBC) as a shield for financial misconduct.

The ED's investigation revealed a deliberate strategy to exploit the IBC framework. An application to initiate CIRP against Alchemist Limited was filed by M/s Sai Tech Medicare Pvt. Ltd. Subsequently, a Committee of Creditors (CoC) was constituted, which the ED demonstrated was overwhelmingly dominated by Alchemist Group entities. Notably, M/s Technology Parks Limited held approximately 97% of the voting rights within this CoC. This composition allowed for the potential manipulation of the resolution process to frustrate investigations into alleged money laundering activities. The NCLT's decision to recall the CIRP, nullify the Resolution Professional's appointment, and lift the moratorium signals a strong deterrent against such practices.

Analytical Deep Dive: Financial Misconduct and Regulatory Clash

### The ₹1,842 Crore Financial Web The ED's probe centers on a substantial alleged financial scandal amounting to approximately ₹1,842 crore. Investigations indicate that Alchemist Holdings Limited and Alchemist Township India Limited purportedly raised funds from the public by promising high returns, plots, or villas. However, investors allegedly did not receive the promised assets or refunds. Instead, these funds were allegedly diverted to other group companies, including Alchemist Limited, often through inter-corporate deposits (ICDs). The ED has actively pursued this case, filing prosecution complaints in March 2021, with supplementary complaints in July 2024 and September 2025 before the special Prevention of Money Laundering Act (PMLA) court. Further actions include provisional attachment of assets worth ₹492.72 crore and shares valued at ₹127.33 crore in Alchemist Hospital and Ojas Hospital.

### IBC vs. PMLA: A Legal Tug-of-War
This case highlights the complex interplay between the IBC and the PMLA. While the IBC aims for corporate revival and value maximization, the PMLA, enforced by the ED, targets the recovery of proceeds from criminal activities like money laundering. The ED successfully argued that the insolvency proceedings were designed to legitimize proceeds of crime and obstruct PMLA investigations. Section 65 of the IBC itself penalizes the initiation of insolvency proceedings with fraudulent or malicious intent, a provision the NCLT invoked. Courts have increasingly emphasized that the IBC's moratorium does not grant immunity from PMLA actions, recognizing that assets identified as proceeds of crime cannot be shielded by insolvency proceedings. The NCLT's penalty of ₹5 lakh on Sai Tech Medicare Pvt. Ltd. for initiating a 'malicious insolvency petition' further reinforces this stance.

### Company's Precarious Financial Standing
Delving into Alchemist Limited's financial health reveals a troubled picture, potentially exacerbating the circumstances for such alleged manipulations. For Alchemist Limited (BSE: 526707, NSE: ALCHEM), available data from late 2021 shows a market capitalization of approximately ₹4.08 crore, with a negative book value per share and a negative Return on Capital Employed (ROCE). Reports for Alchemist Corporation Limited (ALCHCORP.BO) indicate a market cap of around ₹12.90 crore and a trailing twelve months (TTM) Price-to-Earnings (P/E) ratio of -45.34, signifying persistent losses. Financials for the year ending March 31, 2020, show a net loss of over ₹46.7 crore and negative operating cash flows, underscoring a challenging financial environment. The limited trading volume and differing valuations across Alchemist entities also point to significant illiquidity and data discrepancies, making traditional market analysis difficult.

Future Outlook: Precedent and Regulatory Vigilance

The NCLT's recall of CIRP against Alchemist Limited serves as a potent reminder of the scrutiny faced by corporate insolvency processes. It underscores the ED's commitment to prosecuting financial crimes and preventing the misuse of legal mechanisms. This action reinforces that regulatory bodies will vigorously pursue those who attempt to use bankruptcy proceedings as a tool to shield illicit financial activities. The precedent established by this ruling is likely to encourage greater diligence from insolvency professionals and creditors, while simultaneously signaling to potential offenders that the boundaries between legitimate resolution and fraudulent intent are being policed more strictly. The outcome reinforces the broader Indian regulatory push for enhanced corporate governance and accountability, particularly in sectors susceptible to large-scale financial manipulation.